"Our sympathies are with those...": AstraZeneca amid concerns over side effects of Covishield

In a case related to a 100 million pound class action lawsuit against the pharmaceutical company in a British court, the company admitted that the vaccine can actually cause thrombosis thrombocytopenia syndrome (TTS) in rare cases.

Bhoomi Goyal
Published on: 1 May 2024 3:55 PM GMT
Our sympathies are with those...: AstraZeneca amid concerns over side effects of Covishield
X

British pharmaceutical company AstraZeneca Vaccine has accepted the dangerous side effects of their Corona Vaccine. The pharma company has admitted that their Covishield vaccine can also cause blood clotting and low platelet count in many rare cases. Along with this, he once again reiterated his commitment regarding the safety of patients. The vaccine made by Serum Institute in India named Covishield is the same formula of AstraZeneca.

This is not the first time that AstraZeneca has acknowledged side effects associated with its corona vaccine. In a case related to a 100 million pound class action lawsuit against the pharmaceutical company in a British court, the company admitted that the vaccine can actually cause thrombosis thrombocytopenia syndrome (TTS) in rare cases.

AstraZeneca issued a statement saying, "Our sympathies are with those who have lost loved ones or have reported health problems. Patient safety is our top priority. To ensure the safe use of all medicines, including vaccines." "Regulatory authorities have clear and stringent standards."

Regulatory agencies around the world have consistently said that the benefits of vaccination outweigh the risks posed by extremely rare side effects. The World Health Organization (WHO) has described the vaccine as "safe and effective for all people aged 18 and over", making legal action over its efficacy "very rare".

Serum Institute of India has developed Covishield COVID-19 vaccine using viral vector platform instead of mRNA technology. The vaccine uses a modified chimpanzee adenovirus, ChAdOx1, to carry the COVID-19 spike protein into human cells. Although this cold virus cannot effectively infect the recipient, it effectively "teaches" the immune system to defend against similar viruses.

Bhoomi Goyal

Bhoomi Goyal

English Content Writer in Newstrack from Jaipur, Rajasthan. (Education, Business, Technology, Political, Sports, Lifestyle, Crime and Webstories)

My self Bhoomi Goyal from Jaipur, Rajasthan. I have passed my Master's in Journalism and Mass Communication this year. I worked in Rajasthan Patrika for six months as an intern. I am working here from June 1st. I passed my graduation in BCA from Rajasthan University and master's in journalism and mass communication from Vivekananda Global University, Jaipur.

Next Story